|  | 
| Study to evaluate immunogenicity and safety of GSK Bios’ MeMuRu-OKA vaccine compared to concomitant administrations of GSK Bios’ Priorix™ and Varilrix™ vaccines | 
| Combined Measles, Mumps, Rubella, Varicella Vaccine | 
| 208136/018 (MeMuRu-OKA-018) | 
|  | 
| Measles; Mumps; Rubella; Varicella | 
| Phase 3 | 
|  | 
|  | 
|  | 
|  | 
| An annotated case report form is not available for this study. A blank case report form will be provided. A link to ClinicalTrials.gov and an NCTID number are not available for this study because the study is not in scope of regulatory requirements to register studies. | 
| September 2015 |